Loading
Annexin Pharmaceuticals AB (publ) Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Nils Anders Haegerstrand, was filed 19 Dec 2023.
Annexin Pharmaceuticals AB (publ): what insiders have been doing
Annexin Pharmaceuticals AB (publ), classified in the Health Care sector, is a listed company. Its insiders report their share dealings to Finansinspektionen. The last twelve months, up to 20 October 2026, brought 2 filings signed by 2 insiders.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
There has been no open-market purchase by an insider of Annexin Pharmaceuticals AB (publ) for at least a year.
Across the 875 companies tracked on its exchange, the median is 8 filings; at 2 filings, this issuer sits below that mark. Our records for Annexin Pharmaceuticals AB (publ) go back to 2018, with 19 purchases and no sales on the open market in total.
Other companies in the same sector with recent insider buying flagged by our signals: Vivos Inc and Anixa Biosciences Inc. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Insider Decl.
26
Thresholds
n/a
Buy Volume
€255,635
19 ops. · all time
Sell Volume
n/a
n/a
Financial data
as of FY 2025FY ended December 2025 · cache
SEK 8.14
Analyst consensus
1 analysts0.00/5
SEK 61.00Target SEK 61.00(+649%)SEK 61.00
Income statement
EBITDA-SEK 36.9M
Net income-SEK 36.9M0.0% margin
Valuation
P/Book22.8x
Beta0.38
Balance sheet & cash
Market capSEK 71M
Free Cash Flow-SEK 37.1M
Profitability & ownership
ROE-177.5%
ROA-90.0%
% insiders55.0%
% institutions4.7%
Last declaration on 16 July 2026
Declarations26 total
5,000 shares@ SEK 12.000.071% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0009664154FI:csv-574670a461c3e110e5ed
435,978 shares@ SEK 12.006.19% mcap28.5% of flowBTA (betald tecknad aktie)ISIN SE0029300896FI:csv-1968a0c13e668f685966
43,251,795 shares@ SEK 0.3013.90% mcap71.5% of flowBTA (betald tecknad aktie)ISIN SE0024173066FI:A003M856-1
635,008 shares@ SEK 0.20BTA (betald tecknad aktie)ISIN SE0021148707FI:csv-1df9e3236aa5a4249016
Canonical exit: 17 Mar 2024 (T+90)
2,910,622 shares@ SEK 0.20BTA (betald tecknad aktie)ISIN SE0009664154FI:csv-1b80db317a7889ee1dcb
300,000 shares@ SEK 0.2116.9% of flowTeckningsoptionFI:csv-013547029588167fa4b6
Canonical exit: 12 Sept 2022 (T+90)
701 shares@ SEK 29.00100.0% of flowAktieISIN SE0015221684FI:csv-3ce791e154d176d7d8db
Canonical exit: 23 Aug 2022 (T+90)
100,000 shares@ SEK 0.869AktieISIN SE0009664154FI:csv-1932ce4684701b60b104
Canonical exit: 13 Jun 2022 (T+90)
100,000 shares@ SEK 0.869AktieISIN SE0017070899FI:csv-bfd1a98e7f06475e0e0d
Canonical exit: 13 Jun 2022 (T+90)
60,000 shares@ SEK 1.25BTU (betald tecknad unit)ISIN SE0009664154FI:csv-292ff3c87477575083cc
150,000 shares@ SEK 1.25BTU (betald tecknad unit)ISIN SE0017070865FI:csv-284ac904249b34b41cd0
Canonical exit: 23 Jan 2022 (T+90)
75,000 shares@ SEK 1.25BTU (betald tecknad unit)ISIN SE0017070865FI:csv-ea0281d23caca8599de8
75,000 shares@ SEK 1.25BTU (betald tecknad unit)ISIN SE0009664154FI:csv-f5ac5679155ceee2b7ad
164,761 shares@ SEK 0.3250.0% of flowTeckningsoptionFI:csv-292b1d59359914648249
Canonical exit: 7 Apr 2021 (T+90)
164,761 shares@ SEK 0.32100.0% of flowTeckningsoptionFI:A001P381-1
Canonical exit: 7 Apr 2021 (T+90)
3,000 shares@ SEK 1.783.7% of flowAktieISIN SE0009664154FI:csv-a19b5ac35715736c0d3a
Canonical exit: 23 Mar 2021 (T+90)
40,688 shares@ SEK 1.8051.1% of flowAktieISIN SE0009664154FI:csv-80787484ee9b1272c617
Canonical exit: 23 Mar 2021 (T+90)
2,145 shares@ SEK 1.7952.7% of flowAktieISIN SE0009664154FI:csv-d50090191b104c533382
Canonical exit: 23 Mar 2021 (T+90)
2,169 shares@ SEK 1.7752.7% of flowAktieISIN SE0009664154FI:csv-14684f86517a057bfe60
Canonical exit: 23 Mar 2021 (T+90)
2,000 shares@ SEK 1.772.5% of flowAktieISIN SE0009664154FI:csv-378c4e0db57ebb4610bf
Canonical exit: 23 Mar 2021 (T+90)
29,998 shares@ SEK 1.7837.3% of flowAktieISIN SE0009664154FI:csv-6e0c931c297485b23306
Canonical exit: 23 Mar 2021 (T+90)
38,452 shares@ SEK 1.593.3% of flowAktieISIN SE0009664154FI:csv-7127c6f67d82c3e07b72
Canonical exit: 9 Jun 2019 (T+90)
94,410 shares@ SEK 8.8045.4% of flowISIN SE0011167451FI:csv-32ed0e3c76abeda4e89d
Canonical exit: 27 Aug 2018 (T+90)
94,410 shares@ SEK 8.8045.8% of flowFI:csv-b7c3e4c394b4cfad2324
Canonical exit: 23 Aug 2018 (T+90)
11,364 shares@ SEK 8.805.5% of flowFI:csv-78b402d9f67a8e634b2b
Canonical exit: 22 Aug 2018 (T+90)
25 of 26 declarations
About Annexin Pharmaceuticals AB (publ)
Annexin Pharmaceuticals AB (publ) is a Swedish pharmaceutical company focused on developing treatments for inflammatory diseases and cardiovascular disorders. It is listed on the Stockholm Stock Exchange (XSTO).
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
